Cel Sci (CVM) Receivables (2011 - 2021)
Cel Sci (CVM) recorded Receivables of $54,922 in fiscal Q1 2022 (quarter ended Dec 31, 2021), unchanged from $54,922 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Receivables (2011 - 2021) Analysis & Trends
Starting with fiscal Q3 2011, Cel Sci's Receivables history includes 43 quarters.
- Annual Receivables has a five-year compound annual growth rate of -32.6% (FY2016 to FY2021).
- Across earlier fiscal years, Receivables came in at $54,922 in FY2020 (-12.5%), $62,765 in FY2019 (-47.1%), $118,657 in FY2018 (-45.7%) and $218,481 in FY2017 (-44.6%).
- Quarterly Receivables has ranged from $4,252 in fiscal Q2 2017 to $271,737 in fiscal Q3 2017 over the past five years.
- On a year-over-year basis, Receivables rose in 1 of the last eight quarters, with an average decline of 9.5%.
- Peak year-over-year performance for Receivables in the last five years was growth of 170.5% in fiscal Q1 2019, against a decline of 99.4% in fiscal Q2 2017 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $54,922 (Q4 2021), $54,922 (Q3 2021) and $54,922 (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 54,922.00 |
| Sep 30, 2021 | 54,922.00 |
| Jun 30, 2021 | 54,922.00 |
| Mar 31, 2021 | 54,922.00 |
| Dec 31, 2020 | 54,922.00 |
| Sep 30, 2020 | 54,922.00 |
| Jun 30, 2020 | 255,007.00 |
| Mar 31, 2020 | 62,289.00 |
| Dec 31, 2019 | 91,043.00 |
| Sep 30, 2019 | 62,765.00 |
| Jun 30, 2019 | 118,264.00 |
| Mar 31, 2019 | 123,236.00 |
| Dec 31, 2018 | 128,762.00 |
| Sep 30, 2018 | 118,657.00 |
| Jun 30, 2018 | 119,652.00 |
| Mar 31, 2018 | 136,783.00 |
| Dec 31, 2017 | 47,610.00 |
| Sep 30, 2017 | 218,481.00 |
| Jun 30, 2017 | 271,737.00 |
| Mar 31, 2017 | 4,252.00 |
API Access
Cel Sci Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();